Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Boucher

Showing results (571-580 of 682) with videos related to

Pageof 69
Sort By:
Molecular Therapy Oncolytics|December 11, 2023
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemiaJustin C Boucher, Bishwas Shrestha, Paresh Vishwasrao, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Conditionally reprogrammed cells represent a stem-like state of adult epithelial cellsFrank A Suprynowicz, Geeta Upadhyay, Ewa Krawczyk, et al.
Plos Biology|July 22, 2009
CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epitheliumLiqun Zhang, Brian Button, Sherif E Gabriel, et al.
Thorax|January 29, 2011
Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosisM M Tunney, E R Klem, A A Fodor, et al.
Journal of Traumatic Stress|March 19, 2016
Treatment of Mental or Physical Health Problems in a Combat Zone: Comparisons of Postdeployment Mental Health and Early Separation From ServiceTerry L Conway, Emily A Schmied, Gerald E Larson, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 3, 2013
Acute hyperkalemia associated with inhalation of a potent ENaC antagonist: Phase 1 trial of GS-9411Thomas G O'Riordan, Karl H Donn, Peter Hodsman, et al.
Antiviral Therapy|January 1, 1996
Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Loviride Collaborative Study GroupS Staszewski, V Miller, A Kober, et al.
Molecular Therapy. Methods & Clinical Development|July 25, 2018
An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene TherapyGregg A Duncan, Namho Kim, Yanerys Colon-Cortes, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
The Th1/Th17 axis regulates chimeric antigen receptor (CAR) T cell therapy toxicitiesPayal Goala, Yongliang Zhang, Cooper Sailer, et al.
Journal of Clinical Microbiology|November 12, 2010
Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centersFranziska A Stressmann, Geraint B Rogers, Erich R Klem, et al.
Pageof 69

Showing results (571-580 of 682) with videos related to

Sort By:
Pageof 69
Molecular Therapy Oncolytics|December 11, 2023
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemiaJustin C Boucher, Bishwas Shrestha, Paresh Vishwasrao, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Conditionally reprogrammed cells represent a stem-like state of adult epithelial cellsFrank A Suprynowicz, Geeta Upadhyay, Ewa Krawczyk, et al.
Plos Biology|July 22, 2009
CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epitheliumLiqun Zhang, Brian Button, Sherif E Gabriel, et al.
Thorax|January 29, 2011
Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosisM M Tunney, E R Klem, A A Fodor, et al.
Journal of Traumatic Stress|March 19, 2016
Treatment of Mental or Physical Health Problems in a Combat Zone: Comparisons of Postdeployment Mental Health and Early Separation From ServiceTerry L Conway, Emily A Schmied, Gerald E Larson, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 3, 2013
Acute hyperkalemia associated with inhalation of a potent ENaC antagonist: Phase 1 trial of GS-9411Thomas G O'Riordan, Karl H Donn, Peter Hodsman, et al.
Antiviral Therapy|January 1, 1996
Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Loviride Collaborative Study GroupS Staszewski, V Miller, A Kober, et al.
Molecular Therapy. Methods & Clinical Development|July 25, 2018
An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene TherapyGregg A Duncan, Namho Kim, Yanerys Colon-Cortes, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
The Th1/Th17 axis regulates chimeric antigen receptor (CAR) T cell therapy toxicitiesPayal Goala, Yongliang Zhang, Cooper Sailer, et al.
Journal of Clinical Microbiology|November 12, 2010
Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centersFranziska A Stressmann, Geraint B Rogers, Erich R Klem, et al.
Pageof 69